Medication info
Rosawin 50 mg (Losartan Potassium)

Rosawin 50 mg (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
Cosmax Pharma Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201900245 · Approved 2019.01.18

Summary

Main use
Treatment of hypertension; treatment of kidney disease in patients with type 2 diabetes and hypertension
Who takes it
Adults · Children
Adult dose
1. Hypertension Adults The recommended initial and maintenance dose is 50 mg orally once daily as losartan potassium. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is inadequate, the same dose may be divided and administered orally twice daily, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with other antihypertensive agents (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). 3. Special populations Older adults No adjustment of the initial dose is required in older adults aged 75 years or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is required. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced effective intravascular volume An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced effective intravascular volume (e.g., patients receiving diuretic therapy) (see Precautions for Use). Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Pediatric patients and adolescents 6 years of age and older, weighing 20 kg or more but less than 50 kg, who can swallow tablets: The recommended dose is 25 mg of this medicine once daily; it may be increased to a maximum of 50 mg once daily according to the patient's blood pressure response. Pediatric patients and adolescents 6 years of age and older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Not recommended for pediatric patients younger than 6 years, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Ingredients

Manufacturer
Cosmax Pharma Co., Ltd.

Efficacy & effects

Treatment of hypertension; treatment of kidney disease in patients with type 2 diabetes and hypertension

  • Hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used for the treatment of hypertension, especially useful in managing kidney disease in patients with type 2 diabetes and hypertension. It is effective in preventing kidney damage caused by hypertension and diabetes and protecting kidney function, thereby contributing to reducing complications associated with hypertension and maintaining health.

How to take

Adult dose

1. Hypertension Adults The recommended initial and maintenance dose is 50 mg orally once daily as losartan potassium. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is inadequate, the same dose may be divided and administered orally twice daily, or the dose may be increased to 100 mg once daily if necessary. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with other antihypertensive agents (e.g., a low-dose diuretic). An additive effect has been observed with concomitant administration of hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily according to blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antidiabetic agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). 3. Special populations Older adults No adjustment of the initial dose is required in older adults aged 75 years or younger. For older adults over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Patients with renal impairment Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is required. Creatinine clearance < 20 mL/min and patients on dialysis: An initial dose of 25 mg of this medicine once daily is recommended. Patients with reduced effective intravascular volume An initial dose of 25 mg of this medicine once daily is recommended for patients who may have reduced effective intravascular volume (e.g., patients receiving diuretic therapy) (see Precautions for Use). Patients with hepatic impairment Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Pediatric patients and adolescents 6 years of age and older, weighing 20 kg or more but less than 50 kg, who can swallow tablets: The recommended dose is 25 mg of this medicine once daily; it may be increased to a maximum of 50 mg once daily according to the patient's blood pressure response. Pediatric patients and adolescents 6 years of age and older, weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily; it may be increased to a maximum of 100 mg once daily according to the patient's blood pressure response. Not recommended for pediatric patients younger than 6 years, pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡, or pediatric patients with hepatic impairment.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy, especially in the second and third trimesters. Therefore, it should not be taken by pregnant women or women who may become pregnant. Patients who have hypersensitivity to this medication or specific conditions such as severe liver impairment, hereditary angioedema, or primary aldosteronism should not use it. Caution should be taken in elderly patients, those with hyperkalemia, liver impairment, cardiovascular diseases, or decreased kidney function as blood pressure and kidney function should be monitored regularly. Muscle cramps, dizziness, cough, and dyspepsia may occur; if these symptoms are severe, consult a physician. If symptoms such as extremely low blood pressure or worsening kidney function occur, notify healthcare personnel immediately. This medication may interact with certain other drugs, so inform your doctor or pharmacist if you are taking other medications, especially potassium supplements or potassium-sparing diuretics. Pregnant or breastfeeding women should avoid this medication, and if necessary, should discontinue breastfeeding after consulting a specialist. This drug should not be administered to children, especially those under 6 years of age or those with severely impaired kidney function. While taking this medication, caution is necessary when driving or operating machinery as dizziness or drowsiness may occur. Store in a place inaccessible to children and avoid transferring to other containers.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • back pain
  • limb pain
  • dizziness
  • congestion
Show 124 more
  • upper respiratory tract infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus dysfunction
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • bloat
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm skin peeling
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • 2nd degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscular rigidity
  • arthralgia
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • decreased libido
  • memory impairment
  • migraine
  • neural hyperexcitability
  • sensory abnormalities
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnolence
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • purpura
  • erythema
  • flushing
  • photosensitivity
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • ocular burning
  • ocular pain
  • conjunctivitis
  • taste disturbance
  • tinnitus
  • decreased vision
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urethral infection
  • dry cough
  • vascular edema
  • vasculitis
  • anaphylaxis-like syndrome
  • impaired liver function
  • hepatitis
  • intestinal vascular edema
  • fatigue
  • thrombocytopenia
  • elevated creatine kinase
  • rhabdomyolysis
  • acute renal failure
  • erythematous skin disease
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beats
  • hypoglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it must be stored in a closed container. Keep the storage temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.